Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis

OBJECTIVES: To assess the efficacy and safety of abatacept, a selective T-cell costimulation modulator, in a phase III study in psoriatic arthritis (PsA). METHODS: This study randomised patients (1:1) with active PsA (~60% with prior exposure to a tumour necrosis factor inhibitor) to blinded weekly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Rheum Dis
Main Authors: Mease, Philip J, Gottlieb, Alice B, van der Heijde, Désirée, FitzGerald, Oliver, Johnsen, Alyssa, Nys, Marleen, Banerjee, Subhashis, Gladman, Dafna D
Formato: Artigo
Idioma:Inglês
Publicado em: Annals of the Rheumatic Diseases 2017
Assuntos:
Clinical and Epidemiological Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5561378/
https://ncbi.nlm.nih.gov/pubmed/28473423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2016-210724
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados